Technology breakthrough reveals cellular transcription process
2014-12-04
(Press-News.org) This news release is available in French.
A new technology that reveals cellular gene transcription in greater detail has been developed by Dr. Daniel Kaufmann of the University of Montreal Hospital Research Centre (CRCHUM) and the research team he directed. "This new research tool offers us a more profound view of the immune responses that are involved in a range of diseases, such as HIV infection. At the level of gene transcription, this had been difficult, complex and costly to do with current technologies, such as microscopy," explained the University of Montreal professor.
The technology is known as the "FISH investigation protocol" (Fluorescent in situ hybridization) - it optimises current flow cytometry processes, resulting in a greater visibility of the transcription of RNA, a key step in the transmission of cellular information. The researchers published their breakthrough in Nature Communications' online edition. Flow cytometry itself enables the simultaneous measurement of hundreds of thousands of cells as they quickly pass through laser beams. This technology dates back to 1934, when it was used to count the cells making up organs and blood, before being developed across the decades to enable the analysis of cells' various physical characteristics. Today, flow cyclometers are standard equipment for immunology and cancer research labs.
However, the tool's major barrier was that it could only be used for the study of proteins, as specific antibodies that recognize these molecules make them visible by marking. Unfortunately, there are many proteins for which no specific antibodies are available, and so it has been impossible to study them with flow cytometry. Moreover, cancer, HIV and other diseases are caused by a problem that precedes cells' creation of proteins - the deregulation of the transcription of DNA information to the RNA messenger. Classic flow cytometry cannot examine what is happening during this process.
Dr Kaufmann's team worked with Affymetrix, a company, to break through this barrier by applying their technology to a fundamental step in the transmission of genetic information within the cell. The technology, which is now patented, involves carefully mixing chemical reactants by following a two day long handling protocol. Using a standard flow cyclometer, a hybridization oven and a variety of meticulously dosed solutions (which act as microscopic fluorescent probes), the cells can be coaxed to deliver information that has been previously unavailable.
The application of the technology promises to have a huge impact as ultimately it will enable researchers to better understand the mechanisms that cause diseases and to establish the efficacy of the drugs used to treat them. "In principle, our technology can be applied to any species. We can detect a very wide variety of RNA molecules produced by the human body and animals," Dr. Kaufmann explained.
INFORMATION:
About this study
This study was financed by the National Institutes of Health in Washington, DC. Dr Daniel Kaufmann received a bourse de carrière from Fonds de recherche du Québec - Santé. The team he directed included researchers from the Ragon Institute (Boston) and the CRCHUM. The lead author, Dr. Filippos Porichis of the Ragon Institute, led most of the experiments. Affymetrix, a company, also participated in this study. The University of Montreal Hospital (CHUM) and the University of Montreal are known officially as Centre hospitalier de l'Université de Montréal and Université de Montréal, respectively.
ELSE PRESS RELEASES FROM THIS DATE:
2014-12-04
The first scientific evidence of frankincense being used in Roman burial rites in Britain has been uncovered by a team of archaeological scientists led by the University of Bradford. The findings - published today in the Journal of Archaeological Science - prove that, even while the Roman Empire was in decline, these precious substances were being transported to its furthest northern outpost.
The discovery was made by carrying out molecular analysis of materials previously thought to be of little interest - debris inside burial containers and residues on skeletal remains ...
2014-12-04
Vienna, Austria - 04 December 2014: Non-ergot derived dopamine agonists used to treat Parkinson's disease may be safe for the heart, according to preliminary research presented at EuroEcho-Imaging 2014 by Dr Hilal Erken Pamukcu, cardiologist at Ankara Diskapi Education and Research Hospital in Turkey.
EuroEcho-Imaging is the annual meeting of the European Association of Cardiovascular Imaging (EACVI), a registered branch of the European Society of Cardiology (ESC), and is held 3-6 December in Vienna, Austria.
Dr Erken Pamukcu said: "Parkinson's disease is a neurological ...
2014-12-04
Many patients with first-episode psychosis receive medications that do not comply with recommended guidelines for first-episode treatment, researchers have found. Current guidelines emphasize low doses of antipsychotic drugs and strategies for minimizing the side effects that might contribute to patients stopping their medication. A study finds that almost 40 percent of people with first-episode psychosis in community mental health clinics across the country might benefit from medication treatment changes.
Psychosis is a mental disorder in which thoughts and emotions ...
2014-12-04
It has been a long held belief that tumors arising from exposure to asbestos are caused by mutations in one cell, which then produces multiple clones. This hypothesis is challenged by new research published in the open access Journal of Translational Medicine, which suggests it is caused by mutations in multiple cells.
Malignant mesothelioma is a rare form of cancer that affects the mesothelium - the protective lining that covers the internal organs, such as the lungs, the heart and the abdominal cavity. It is estimated that malignant mesothelioma affects up to 3,200 ...
2014-12-04
Some previous studies have linked the diabetes medication pioglitazone to bladder cancer. However a new study − including more than one million people in six populations worldwide − has found no link between either pioglitazone or rosiglitazone (also known as Avandia) and bladder cancer. The new study is published in Diabetologia (the journal of the European Association for the Study of Diabetes), and is by Dr Samira Bell, Professor Helen Colhoun and Mr Danny Levin, University of Dundee, UK, and colleagues from the International Diabetes and Cancer Research ...
2014-12-04
Children born prematurely are at an increased risk of flu-related complications, despite not being identified as an "at risk" group in UK, USA, or WHO guidelines, and should be a priority group for the seasonal flu vaccination, new research published in The Lancet Respiratory Medicine suggests.
"Until now, guidelines highlighting groups at greater risk of developing complications from influenza, such as pneumonia, have been based on consensus opinion rather than on systematic assessment of the evidence"*, explains Dr Kay Wang from the University of Oxford in the UK. ...
2014-12-04
Researchers at the National Institutes of Health have found a duplication of a short stretch of the X chromosome in some people with a rare disorder that causes excessive childhood growth. They believe that a single gene within the region likely has a large influence on how much children grow. The research comes from a lab at NIH's Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which seeks to understand growth.
"Finding the gene responsible for childhood overgrowth would be very helpful, but the much wider question is what ...
2014-12-04
HOUSTON - (Dec. 3, 2014) - Rice University scientists have discovered an environmentally friendly carbon-capture method that could be equally adept at drawing carbon dioxide emissions from industrial flue gases and natural gas wells.
The Rice lab of chemist Andrew Barron revealed in a proof-of-concept study that amine-rich compounds are highly effective at capturing the greenhouse gas when combined with carbon-60 molecules.
The research is the subject of an open-access paper today in Nature's online journal Scientific Reports.
"We had two goals," Barron said. "One ...
2014-12-03
The longer surgery lasts the more prone patients appear to be to develop blood clots (venous thromboembolisms, VTE), according to a report published online by JAMA Surgery.
The association between longer surgical procedures and death, including VTE, is widely accepted but it has yet to be quantitatively addressed. More than 500,000 hospitalizations and 100,000 deaths are associated each year with VTEs. Examining the link between VTE and surgical time could allow for more informed medical and surgical decisions, according to the study background.
John Y.S. Kim, M.D., ...
2014-12-03
CHICAGO --- The longer the duration of surgery, the higher the risk of a life-threatening blood clot, according to the first large-scale, quantitative national study of the risk across all surgical procedures.
The Northwestern Medicine study was published Dec. 3 in JAMA Surgery, the Journal of the American Medical Association.
The finding will help guide surgical decision-making by enabling surgeons and patients to better understand the potential risk of procedures. These findings may also spur surgeons to take more aggressive preventative measures such as giving ...
LAST 30 PRESS RELEASES:
[Press-News.org] Technology breakthrough reveals cellular transcription process
